ArticleApplied health economics and health policy2012
Estimating incremental costs with skew: a cautionary note.
Article in Applied health economics and health policy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Meta-analysis of economic evaluation studies: data harmonisation and methodological issues.BMC health services research · 2022Pooled it
- Health economic evaluation alongside randomised clinical trial of a health behaviour intervention to manage type 2 diabetes in Nepal.Global health research and policy · 2024Trial
- Trial
- Disease burden and health-related quality of life among adults aged 50 years or older with herpes zoster in Huzhou, China.Frontiers in public health · 2026Article
- The Relationship of Alzheimer's Disease and Related Dementias Blood-Based Biomarkers and Informant-Reported Neuropsychiatric Symptoms Differs by Informant Type in Older Adults Without Dementia.International journal of geriatric psychiatry · 2025Article
- Economic burden due to COVID-19 in a Colombian Caribbean state, 2020 and 2021.Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil · 2024Article
- Is ultra-hypo-fractionated radiotherapy more cost-effective relative to conventional fractionation in treatment of prostate cancer? A cost-utility analysis alongside a randomized HYPO-RT-PC trial.The European journal of health economics : HEPAC : health economics in prevention and care · 2023Article
- Observational
- Coming Complications of Nonalcoholic Fatty Liver Disease: Time to GNASH Your Teeth.Digestive diseases and sciences · 2019Article
- Effect of improved medication adherence on health care costs in osteoporosis patients.Medicine · 2018Observational
- The Hospitalization Costs of Diabetes and Hypertension Complications in Zimbabwe: Estimations and Correlations.Journal of diabetes research · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundCost data in healthcare are often skewed across patients. Thus, researchers have used either a log transformation of the dependent variable or generalized linear models with log links. However, frequently these non-linear approaches produce non-linear incremental effects: the incremental effects differ at different levels of the covariates, and this can cause dramatic effects on predicted cost.
objectivesThe aim of this study was to demonstrate that when modelling skewed data, log link functions or log transformations are not necessary and have unintended effects.
methodsWe simulated cost data using a linear model with a 'treatment', a covariate and a specified number of observations with excessive cost (skewed data). We also used actual data from a pain-relief intervention among hip-replacement patients. We then estimated cost models using various functional approaches suggested to handle skew and calculated the incremental cost of treatment at various levels of the covariate(s).
resultsAll of these methods provide unbiased estimates of the incremental effect of treatment on costs at the mean level of the covariate. However, in some log-based models the implied incremental treatment cost doubled between extreme low and high values of the covariate in a manner inconsistent with the underlying linear model.
conclusionsAlthough specification checks are always needed, the potential for misleading incremental estimates resulting from log-based specifications is often ignored. In this era of cost containment and comparisons of treatment effectiveness it is vital that researchers and policymakers understand the limitation of the inferences that can be made using log-based models for patients whose characteristics differ from the sample mean.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.